20068 ⎘
Medicinal preparations characterised by special physical form; Dispersions; Emulsions; Liposomes Non-vesicle bilayer structures, e.g. liquid crystals, tubules, cubic phases, cochleates; Sponge phases
COMPOSITIONS AND METHODS OF USE THEREOF FOR PREVENTION OF MASTITIS
#2COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#3SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS
#4NANODISC COMPRISING MEMBRANE SCAFFOLD PROTEIN HAVING FC REGION OF ANTIBODY FUSED THERETO
#5LIPID DEPOT FORMULATIONS
#6COMPOUNDS, COMPOSITIONS AND METHODS FOR DELIVERY OF BIOLOGICALLY ACTIVE AGENTS
#7CONTROLLED RELEASE PEPTIDE FORMULATIONS
#8NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY
#9ENCOCHLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS
#10NON-LAMELLAR LIQUID CRYSTAL-FORMING COMPOSITION AND USE THEREOF
#11COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE
#12NANOLIPOPROTEIN PARTICLES AND RELATED COMPOSITIONS METHODS AND SYSTEMS FOR LOADING RNA
#13PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING VIRUS INFECTIONS, COMPRISING POLYMER NANODISCS
#14Non-liposomal systems for nucleic acid delivery
#15UTIDELONE LIPOSOME COMPOSITION, AND PREPARATION METHOD THEREFOR AND USE THEREOF
#16EMULSION COMPOSITION AND USES THEREOF IN THE PREVENTION AND/OR TREATMENT OF SKIN DAMAGE CAUSED BY RADIATION
#17BIOMIMETIC ARTIFICIAL CELLS: ANISOTROPIC SUPPORTED LIPID BILAYERS ON BIODEGRADABLE MICRO AND NANOPARTICLES FOR SPATIALLY DYNAMIC SURFACE BIOMOLECULE PRESENTATION
#18LIPOSOMES ENCAPSULATING ADENOSINE
#19ANTIMICROBIAL COMPOSITIONS AND METHODS OF USE
#20SOMATOSTATIN RECEPTOR AGONIST FORMULATIONS
#21COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#22SELF-ASSEMBLED GELS FOR CONTROLLED DELIVERY OF BIOLOGICS AND METHODS OF MAKING THEREOF
#23LIPID NANODISC FORMATION BY POLYSACCHARIDES MODIFIED WITH HYDROPHOBIC GROUPS
#24LIPOSOMES ENCAPSULATING ADENOSINE
#25HIGHLY SAFE NON-LAMELLAR LIQUID CRYSTAL FORMING COMPOSITION
#26COMPOSITIONS AND METHODS OF USE THEREOF FOR TREATMENT OF MASTITIS
#27LIPID DEPOT FORMULATIONS
#28TRANSMEMBRANE PORES FORMED BY AROMATIC OLIGOAMIDE FOLDAMERS AND USES OF SAME
#29ORALLY DELIVERED THERAPEUTICAL COMPOSITION AND USE THEREOF
#30METHODS OF TREATING CRYPTOCOCCUS INFECTIONS
#31FUSION PROTEIN NANODISK COMPOSITIONS AND METHODS OF TREATMENT
#32PRODUCTION OF SALIPRO PARTICLES
#33TOPICAL FORMULATIONS WITH LIPID-BASED CARRIERS
#34Liposomes encapsulating adenosine
#35Lecithin vesicles for oral delivery
#36NANOCRYSTALLINE EYE DROP, PREPARATION METHOD AND USE THEREOF
#37NANODISCS FOR PREVENTING AND TREATING PATHOGEN INFECTIONS AND METHODS OF USE THEREOF
#38ENCHOLEATED ANTIFUNGAL COMPOUNDS FOR CENTRAL NERVOUS SYSTEM DELIVERY AND TREATMENT OF CRYPTOCOCCUS INFECTIONS
#39Discoidal nano universal platform for efficient delivery of PNAs
#40Transmembrane pores formed by aromatic oligoamide foldamers and uses of same
#41CONTROLLED RELEASE PEPTIDE FORMULATIONS
#42Non-liposomal systems for nucleic acid delivery
#43LIPID DEPOT FORMULATIONS
#44Compartmentalised gel matrix and method of production
#45Cochleates made with soy phosphatidylserine
#46TREATMENT USING DANTROLENE
#47NANOCOCHLEATE FORMULATION AND METHOD OF PREPARING THE NANOCOCHLEATE FORMULATION
#48CONTROLLED-RELEASE FORMULATIONS
#49FORMULATION OF FISH VACCINE BASED ON LIPIDIC NANOVESICLES, IN PARTICULAR, A PROTEOLIPOSOME OR COCHLEATE, WITH ACTIVITY AGAINST THE SALMONID RICKETTSIAL SYNDROME (SRS)
#50Polymer nanodiscs for biotechnology and medical applications
#51Lecithin vesicles for oral delivery
#52Transmembrane pores formed by aromatic oligoamide foldamers and uses of same
#53Encholeated antifungal compounds for central nervous system delivery and treatment of infections
#54Polynucleotides encoding lipoprotein lipase for the treatment of hyperlipidemia
#55LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT
#56Treatment using dantrolene
#57Multilayered emulsion film and method for preparing the same
#58COMPOSITIONS AND METHODS FOR TREATING AND AMELIORATING RESPIRATORY CONDITIONS AND INFLAMMATION OF MUCOSA
#59NON-LIPOSOMAL SYSTEMS FOR NUCLEIC ACID DELIVERY
#60Nanolipoprotein particles and related compositions methods and systems for loading RNA
#61LIPID DEPOT FORMULATIONS
#62BIOMIMETIC ARTIFICIAL CELLS: ANISOTROPIC SUPPORTED LIPID BILAYERS ON BIODEGRADABLE MICRO AND NANOPARTICLES FOR SPATIALLY DYNAMIC SURFACE BIOMOLECULE PRESENTATION
#63SALIPRO PARTICLES
#64ACID CONTAINING LIPID FORMULATIONS
#65Cochleates made with soy phosphatidylserine
#66COMPOSITIONS AND METHODS FOR TREATING MYCOBACTERIA INFECTIONS AND LUNG DISEASE
#67Treatment using dantrolene
#68Thermostable vaccines based on ether lipids and native viral envelope proteins
#69GNRH ANALOGUE FORMULATIONS
#70Carriers for Plasmid and RNP Delivery in the Treatment of Cancer and Other Disease States
#71Cochleates and methods of using the same to enhance tissue penetration of pharmacologically active agent
#72Vitamin A composition
#73Methods and systems for treating or preventing cancer
#74Brain and neural treatments comprising peptides and other compositions
#75Topical systems and methods for treating sexual dysfunction
#76Method for producing porous particle
#77MODIFICATIONS OF SOLID 3-SN-PHOSPHOGLYCERIDES
#78Memory or learning improvement using peptide and other compositions
#79LIPID FORMULATIONS COMPRISING A THIOLATED ANTIOXIDANT
#80Topical nitric oxide systems and methods of use thereof
#81Treatment and prevention of learning and memory disorders
#82Topical systems and methods for treating sexual dysfunction
#83Non-liposomal systems for nucleic acid delivery
#84Treatment using dantrolene
#85Methods and systems for treating or preventing cancer
#86Brain and neural treatments comprising peptides and other compositions
#87Salipro particles
#88Treatment using dantrolene
#89Topical systems and methods for treating sexual dysfunction
#90Cancer treatments and compositions for use thereof
#91Treatment and prevention of learning and memory disorders
#92Non-liposomal systems for nucleic acid delivery
#93Composition for gene delivery comprising chitosan and liquid crystal formation material
#94Composition of external application to skin
#95COCHLEATES MADE WITH SOY PHOSPHATIDYLSERINE
#96SUSTAINED-RELEASE LIPID PRE-CONCENTRATE OF CATIONIC PHARMACOLOGICALLY ACTIVE SUBSTANCE AND PHARMACEUTICAL COMPOSITION COMPRISING THE SAME
#97Internal structured self assembling liposomes
#98Lipid assemblies comprising anionic lysolipids and use thereof
#99Cochleates made with soy phosphatidylserine
#100Topical bioadhesive formulations
#101Cochleates made with soy phosphatidylserine
#102Somatostatin receptor agonist formulations
#103LIPID DEPOT FORMULATIONS
#104Cancer treatments and compositions for use thereof
#105Treatment and prevention of learning and memory disorders
#106Robust controlled-release formulations
#107Robust controlled-release peptide formulations
#108Topical systems and methods for treating sexual dysfunction
#109Brain and neural treatments comprising peptides and other compositions
#110Memory or learning improvement using peptide and other compositions
#111Methods and systems for treating or preventing cancer
#112Encochleation methods, cochleates and methods of use
#113Skin composition for external use containing ceramides
#114NOVEL COCHLEATE FORMULATIONS
#115COCHLEATE COMPOSITIONS AND METHODS OF MAKING AND USING SAME
#116Cochleate compositions directed against expression of proteins
#117Controlled release peptide formulations
#118Topical nitric oxide systems and methods of use thereof
#119Treatment using dantrolene
#120Protein free surfactant composition for pulmonary diseases and a process for preparing the same
#121Non-liposomal systems for nucleic acid delivery
#122Geodate delivery vehicles
#123Aqueous dispersion comprising galactolipids and method for production thereof
#124Topical nitric oxide systems and methods of use thereof
#125Reverse hexagonal mesophases (H) and uses thereof
#126NOVEL COCHLEATE FORMULATIONS
#127MODIFICATIONS OF SOLID 3-sn-PHOSPHOGLYCERIDES
#128Cochleate compositions directed against expression of proteins
#129Lipid depot formulations
#130Antibiotic drug delivery and potentiation
#131Amphiphilic nucleotide cochleate compositions and methods of using the same
#132Geodate delivery vehicles
#133NUCLEOTIDE-COCHLEATE COMPOSITIONS AND METHODS OF USE
#134Treatment using dantrolene
#135Treatment using dantrolene
#136Robust Hybrid Thin Films that Incorporate Lamellar Phospholipid Bilayer Assemblies and Transmembrane Proteins
#137Acid containing lipid formulations
#138Methods and compositions for novel liquid crystal delivery systems
#139ORGANOGEL COMPOSITIONS AND PROCESSES FOR PRODUCING
#140Lipid formulations comprising a thiolated antioxidant
#141STIMULATABLE ASYMMETRICAL POLYMERSOME
#142Modifications of solid 3-sn-phosphoglycerides
#143OPHTHALMIC FORMULATIONS OF REVERSED LIQUID CRYSTALLINE PHASE MATERIALS AND METHODS OF USING
#144Nanotubes as mitochondrial uncouplers
#145ANTI-SNORING TREATMENT COMPRISING POSITIVELY CHARGED MULTILAMELLAR MICROPARTICLES
#146Nanotubes as mitochondrial uncouplers
#147Cochleate compositions directed against expression of proteins
#148Method of enhancing transdermal absorption using a composition comprising POE octyl dodecyl ether and squalane
#149CD133 epitopes
#150Method of Treating a Tumor and Biodistribution of a Drug Delivered by Worm-Like Filomicelles
#151Stabilized uncoated particles of reversed liquid crystalline phase materials
#152Stabilized uncoated particles of reversed liquid crystalline phase materials
#153DERMATOLOGICAL COMPOSITIONS COMPRISING VITAMIN D LIPID VESICLES
#154Compositions of spores of non pathogenic bacteria
#155Stabilized uncoated particles of reversed liquid crystalline phase materials
#156AMPHIPHILIC NUCLEOTIDE COCHLEATE COMPOSITIONS AND METHODS OF USING THE SAME
#157CHIMERIC CANNULAE PROTEINS AND METHODS FOR MAKING AND USING THEM
#158Treatment using dantrolene
#159MEMBRANE(S) AND USES THEREOF
#160CONTROLLING THE SYNTHESIS AND GEOMETRY OF LIPID TUBULE NETWORKS
#161GnRH analogue formulations
#162Lysophospholipids Solubilized Single-Walled Carbon Nanotubes
#163Topical bioadhesive formulations
#164Synthesis and use of cationic steroids for anti-inflammatory drug therapy
#165TRANSDERMAL ABSORPTION ENHANCER
#166Compositions and methods for less immunogenic protein-lipid complexes
#167COMPOSITIONS AND METHODS FOR NUCLEIC ACID DELIVERY SYSTEMS
#168COCHLEATES WITHOUT METAL CATIONS AS BRIDGING AGENTS
#169Novel cochleate formulations
#170Modifications of solid 3-sn-phosphoglycerides
#171Biomimetic materials for protein storage and transport
#172Self Assembled Nanotubes and Methods for Preparation Thereof
#173Oil-in-water emulsion and its use for the delivery of functionality
#174Nucleotide-Cochleate Compositions And Methods Of Use
#175Ternary non-lamellar lipid compositions
#176Self-assembling membranes and related methods thereof
#177Immunstimulating lipid formulation
#178PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#179PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#180PHARMACEUTICALLY ACCEPTABLE PHOSPHATE-GLYCEROL CARRYING BODIES
#181Compositions forming non-lamellar dispersions
#182Glp-1 analogue formulations
#183Compositions for the reversal and detoxification of anesthetics and other compounds and methods of their use
#184Controlled-release formulations
#185Liquid depot formulations
#186Cochleate compositions directed against expression of proteins
#187Non-lamellar compositions of DOPE and P80
#188Noval Surfactants and Applications Thereof
#189Hybrid thin films that incorporate lamellar phospholipid layer assemblies and transmembrane proteins
#190Opioid depot formulations
#191Transdermal pharmaceutical composition
#192Encochleation methods, cochleates and methods of use
#193Self assembled nanostructures and methods for preparing the same
#194Composition Comprising Ether Lipid
#195Gene or drug delivery system
#196Pharmaceutical compositions for oral and topical administration
#197Macromolecules auto-assembled and photopolymerised around carbon nanotubes, a method for production and application thereof
#198Composition and delivery system
#199Compositions and methods for less immunogenic protein-lipid complexes
#200Polymer-stabilised, crystallised, catanionic membranes, preparation method thereof and applications of same
#201Chitosan-microparticles for ifn gene delivery
#202Compositions of lipids and cationic peptides
#203Immunstimulating lipid formulation
#204Nanotubes as mitochondrial uncouplers
#205Formulations of quaternary ammonium neuromuscular blocking agents
#206Tabletting process
#207Lipid particles comprising bioactive agents, methods of preparing and uses thereof
#208Coated particles, methods of making and using
#209Replacement enzyme cochleates
#210Apoprotein cochleate compositions
#211Multiblock biodegradable hydrogels for drug delivery and tissue treatment
#212Compositions and methods for less immunogenic protein formulations
#213Encapsulation of chemical compounds in fluorous-core and fluorous-inner-shell micelles formed from semifluorinated-block or fluorinated-block copolymers
#214Polymeric cannulae proteins, nucleic acids encoding them and methods for making and using them
#215Novel cochleate formulations
#216Block co-polymer worm micelles and methods of use therefor
#217Integrative protein-DNA cochleate formulations and methods for transforming cells
#218Treatment methods with low-dose, longer-acting formulations of local anesthetics and other agents
#219New process 1
#220Stabilized uncoated particles of reversed liquid crystalline phase materials
#221Nimesulide containing topical pharmaceutical compositions
#222Cochleate compositions directed against expression of proteins
#223Novel encochleation methods, cochleates and methods of use
#224Cochleate preparations of fragile nutrients